Variant report
Variant | esv2180999 |
---|---|
Chromosome Location | chr6:107124346-107125030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555780134 | chr6:107124346-107124347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536738788 | chr6:107124387-107124388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372326875 | chr6:107124439-107124440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114066479 | chr6:107124440-107124441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572282509 | chr6:107124469-107124470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs13195845 | chr6:107124513-107124514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4276539 | chr6:107124516-107124517 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs564430383 | chr6:107124532-107124533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577839949 | chr6:107124537-107124538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543441159 | chr6:107124540-107124541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4594989 | chr6:107124543-107124544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9386577 | chr6:107124575-107124576 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs4276540 | chr6:107124586-107124587 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
14 | rs558989806 | chr6:107124610-107124611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528705763 | chr6:107124628-107124629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551660164 | chr6:107124684-107124685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571941790 | chr6:107124688-107124689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537333308 | chr6:107124689-107124690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551037988 | chr6:107124740-107124741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567664474 | chr6:107124748-107124749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182677174 | chr6:107124765-107124766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553522300 | chr6:107124784-107124785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543630517 | chr6:107124794-107124795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563324354 | chr6:107124801-107124802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534849200 | chr6:107124802-107124803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146328432 | chr6:107124822-107124823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13198848 | chr6:107124828-107124829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs55832430 | chr6:107124834-107124835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
29 | rs57588043 | chr6:107124838-107124839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs56404130 | chr6:107124848-107124849 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs3121444 | chr6:107124918-107124919 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs188649371 | chr6:107124939-107124940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543349642 | chr6:107124940-107124941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs28460470 | chr6:107124965-107124966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191704469 | chr6:107124971-107124972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573317244 | chr6:107125001-107125002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542187845 | chr6:107125006-107125007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112262749 | chr6:107125007-107125008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371580780 | chr6:107125012-107125013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78367809 | chr6:107125019-107125020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Developmental delay | 21147756 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Autism | 17483303 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
abnormal development | 18461090 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Cancer | 17160897 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Acute lymphoblastic leukemia | 17229543 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:107078600-107125200 | Weak transcription | Stomach Mucosa | stomach |
2 | chr6:107106600-107126200 | Weak transcription | Psoas Muscle | Psoas |
3 | chr6:107114000-107125400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
4 | chr6:107116800-107124800 | Weak transcription | Primary B cells from peripheral blood | blood |
5 | chr6:107116800-107125000 | Weak transcription | Primary B cells from cord blood | blood |
6 | chr6:107117600-107130800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr6:107121000-107125200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr6:107121000-107125200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr6:107121200-107125400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr6:107124800-107126200 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr6:107125000-107126000 | Enhancers | Primary B cells from cord blood | blood |